The L-Cell in Nutritional Sensing and the Regulation of Appetite
At BODYWELLE in Miami Beach, I guide patients through modern weight management options with a clinically rigorous, individualized approach
GLP-1-related hair loss usually manifests as telogen effluvium 24 months after starting treatment or significant weight loss
The landscape shifted in November 2025
People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications
FOR REDUCES HUNGER BY WORKING ON THE BRAINS APPETITE CENTER SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases